Music, Virtual Reality for Patients in IUGM
Music, Virtual Reality and Mental Health of Inpatients in the Intensive Functional Rehabilitation Unit and Patients in the IUGM Geriatric Outpatient Clinic: Pilot Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Promoting good care, well-being and quality of life for geriatric patients is a long-standing initiative in Quebec, and one in which the Institut Universitaire de Gériatrie de Montréal (IUGM) has always been a leader. For example, the IUGM played a major role in drafting the reference framework for the AAPA (approach adapted to the needs of the elderly), which was introduced by the Ministère de la Santé et des Services Sociaux in 2011. The investigator propose to continue this work by focusing in this project on the development of a new intervention aimed at the well-being and quality of life of geriatric patients and based on music and VR. Thee investigator hypothesize (1) that a VR headset-based intervention based on listening to and observing a concert of musicians playing classical music is feasible for patients hospitalized at the IUGM's URFI and in patients attending the geriatric outpatient clinic, and (2) that this intervention can improve their mental health - i.e. their positive emotions, well-being and quality of life - and reduce their anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2024
CompletedFebruary 11, 2025
February 1, 2025
6 months
February 22, 2024
February 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Feasability
To determine if investigator is able to recruit 80 patients in 6 months, with a consent rate of 80% or more and less than 20% of withdrawal
6 months
Secondary Outcomes (5)
Emotions variation
1 day
Affect variation
1 day
Well-Being Variation
1 day
Quality of life variation
1 day
Anxiety variation
1 day
Study Arms (2)
Intervention
EXPERIMENTALparticipants will listen to and watch a concert of musicians playing classical music through a VR headset
Control
ACTIVE COMPARATORparticipants will simply listen to the concert through headphones
Interventions
The participant will be seated comfortably in an armchair. The intervention will last 15 minutes. It will take place once. This group's intervention will be to watch and listen with VR headphones to a concert by a group of musicians playing music.
The participant will be seated comfortably in an armchair. The intervention will last 15 minutes. It will take place once. This group's intervention will be to listen with conventional headphones to a concert by a group of musicians playing music.
Eligibility Criteria
You may qualify if:
- be hospitalized at the URFI of the IUGM, or being a patients attending the geriatric outpatient clinic
- be 60 years of age or older,
- not have an acute intercurrent pathology in the week preceding the procedure and during the two days of the procedure,
- have no psycho-behavioural disorders,
- no major neurocognitive disorder at a severe stage,
- no severe visual or hearing impairment,
- no vestibular balance disorders,
- give written consent to participate in the study.
You may not qualify if:
- Participate in another concurrent experimental clinical study, to avoid interference with our study.
- Do not understand written or spoken French or English. The participants are French and/or English speakers, and the questionnaires are only available in these 2 languages.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CRIUGM
Montreal, Quebec, H3W 1W5, Canada
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, director of AgeTeQ Lab at CRIUGM
Study Record Dates
First Submitted
February 22, 2024
First Posted
March 6, 2024
Study Start
May 1, 2024
Primary Completion
October 23, 2024
Study Completion
October 23, 2024
Last Updated
February 11, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share